Citation: Dc. Matthews et al., Factors affecting patients' and potential patients' choices among anaesthetics for periodontal recall visits, J DENT, 29(3), 2001, pp. 173-179
Authors:
Ruffner, KL
Martin, PJ
Hussell, S
Nourigat, C
Fisher, DR
Bernstein, ID
Matthews, DC
Citation: Kl. Ruffner et al., Immunosuppressive effects of I-131-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models, CANCER RES, 61(13), 2001, pp. 5126-5131
Authors:
Press, OW
Eary, JF
Gooley, T
Gopal, AK
Liu, S
Rajendran, JG
Maloney, DG
Petersdorf, S
Bush, SA
Durack, LD
Martin, PJ
Fisher, DR
Wood, B
Borrow, JW
Porter, B
Smith, JP
Matthews, DC
Appelbaum, FR
Bernstein, ID
Citation: Ow. Press et al., A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, BLOOD, 96(9), 2000, pp. 2934-2942
Citation: Dc. Matthews et al., Preference based measurements in dentistry: a review of the literature andrecommendations for research, COMM DENT H, 16(1), 1999, pp. 5-11
Authors:
Matthews, DC
Birch, S
Gafni, A
DiCenso, A
Citation: Dc. Matthews et al., Willingness to pay for periodontal therapy: Development and testing of an instrument, J PUBL H D, 59(1), 1999, pp. 44-51
Authors:
Matthews, DC
Appelbaum, FR
Eary, JF
Fisher, DR
Durack, LD
Hui, TE
Martin, PJ
Mitchell, D
Press, OW
Storb, R
Bernstein, ID
Citation: Dc. Matthews et al., Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome, BLOOD, 94(4), 1999, pp. 1237-1247
Authors:
Matthews, DC
Martin, PJ
Nourigat, C
Appelbaum, FR
Fisher, DR
Bernstein, ID
Citation: Dc. Matthews et al., Marrow ablative and immunosuppressive effects of I-131-anti-CD45 antibody in congenic and H2-mismatched murine transplant models, BLOOD, 93(2), 1999, pp. 737-745